ArticleJournal of oncology2022

Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling.

Jianchao Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.